Excision BioTherapeutics Funding: $71M Raised, Series A
Excision BioTherapeutics is based in Philadelphia, Pennsylvania. It has raised $71M in total funding. Latest round: Series A.
Excision BioTherapeutics funding overview
Excision BioTherapeutics is based in Philadelphia, Pennsylvania. Excision BioTherapeutics has raised $71M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2021. The round record for Excision BioTherapeutics runs through 2021; nothing later has been disclosed. Investors on record include Alumni Ventures, ARTIS Ventures, Adjuvant Capital, Anzu Partners, Celesta Capital, Cota Capital and 2 others. 8 distinct backers are named across the disclosed rounds.
Excision BioTherapeutics at a glance
Total raised
$71M
Latest round
Series A
Latest round date
February 2021
Headquarters
Philadelphia, Pennsylvania
Notable investors
Alumni Ventures, ARTIS Ventures, Adjuvant Capital, Anzu Partners, Celesta Capital, Cota Capital, Norwest Venture Partners, Olive Tree Capital
Frequently asked about Excision BioTherapeutics funding
How much has Excision BioTherapeutics raised?
Excision BioTherapeutics has raised $71M in total disclosed funding across the rounds on record.
Who has invested in Excision BioTherapeutics?
Alumni Ventures, ARTIS Ventures, Adjuvant Capital, Anzu Partners, Celesta Capital, Cota Capital are named among the investors backing Excision BioTherapeutics.
What was the latest Excision BioTherapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2021.
Where is Excision BioTherapeutics based?
Excision BioTherapeutics is based in Philadelphia, Pennsylvania.
When did Excision BioTherapeutics last raise?
The last disclosed Excision BioTherapeutics round closed in February 2021 at Series A.
Totals shown for Excision BioTherapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Philadelphia and the investors behind them below.
Companies related to Excision BioTherapeutics (36)
